Breaking News Instant updates and real-time market news.

HZNP

Horizon Pharma

$13.02

-0.16 (-1.21%)

10:45
07/17/17
07/17
10:45
07/17/17
10:45

Horizon Pharma call volume above normal and directionally bullish

Bullish option flow detected in Horizon Pharma with 3,847 calls trading, 7x expected, and implied vol increasing almost 5 points to 58.20%. Aug-17 15 calls and Aug-17 11 calls are the most active options, with total volume in those strikes near 3,100 contracts. The Put/Call Ratio is 0.01. Earnings are expected on August 7th.

  • 07

    Aug

HZNP Horizon Pharma
$13.02

-0.16 (-1.21%)

05/09/17
STFL
05/09/17
NO CHANGE
STFL
Horizon Pharma price target lowered to $20 from $35 at Stifel
Stifel analyst Annabel Samimy cut her price target on Horizon after the company reported weaker than expected results and lowered its guidance, citing weakness in its primary care business. Noting that Horizon has decided to "accelerate its transition to an Orphan/Specialty story," the analyst now only ascribes value "to this value/growth driving portion of the business." However, she keeps a Buy rating on the stock.
05/09/17
05/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cisco (CSCO) downgraded to Market Perform from Outperform at BMO Capital with analyst Tim Long saying that the company is facing "share losses in switching and a struggling router market," along with a "contracting" data center business. The analyst says that the company is having difficulty growing its core businesses. 2. DSW (DSW) downgraded to Neutral from Buy at Buckingham with analyst Scott Krasik saying he believes the company's competitive positioning has eroded over the last few years even amid department stores' "demise" playing out. 3. Horizon Pharma (HZNP) downgraded to Neutral from Buy at Mizuho. 4. ChannelAdvisor (ECOM) downgraded to Equal-Weight from Overweight at First Analysis. 5. Realogy (RLGY) downgraded to Neutral from Buy at Compass Point with analyst Frederick Small raising his price target for the shares to $32 from $31. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/07/17
UBSW
06/07/17
NO CHANGE
Target $16
UBSW
Buy
Horizon Pharma weakness a buying opportunity, says UBS
UBS analyst Marc Goodman believes the recent downward move for Horizon Pharma shares was due to frustration by investors who have grown tired of the lack of performance by the company, management's lowered guidance due to lack of visibility, and problems with the company's primary care businesses. Goodman believes the recent weakness is a buying opportunity, though he lowered his price target to $16 from $22 based on his sum-of-the-parts valuation. Goodman maintained his Buy rating on Horizon Pharma shares.
06/16/17
CANT
06/16/17
INITIATION
Target $13
CANT
Overweight
Horizon Pharma initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Louise Chen started Horizon Pharma with an Overweight rating and $13 price target.

TODAY'S FREE FLY STORIES

MDXG

MiMedx

$13.51

0.31 (2.35%)

07:32
10/17/17
10/17
07:32
10/17/17
07:32
Hot Stocks
MiMedx notified by FDA to proceed with Phase 2B IND trial for osteoarthritis »

MiMedx has been notified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 08

    Nov

  • 09

    Nov

  • 10

    Nov

  • 13

    Nov

  • 14

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax, Amneal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

JBL

Jabil Circuit

$28.61

0.37 (1.31%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Recommendations
Jabil Circuit analyst commentary  »

Jabil Circuit strength in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVTCY

Evotec

$51.15

2.3099 (4.73%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Conference/Events
Evotec management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GPRO

GoPro

$9.08

-0.48 (-5.02%)

, CREE

Cree

$29.28

-0.08 (-0.27%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GPRO

GoPro

$9.08

-0.48 (-5.02%)

CREE

Cree

$29.28

-0.08 (-0.27%)

MT

ArcelorMittal

$28.99

-0.36 (-1.23%)

PXD

Pioneer Natural

$143.69

-0.23 (-0.16%)

BABY

Natus Medical

$39.35

-0.75 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 01

    Nov

  • 02

    Nov

CARB

Carbonite

$22.30

-0.5 (-2.19%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Initiation
Carbonite initiated  »

Carbonite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

NEWS

NewStar Financial

$12.13

0.23 (1.93%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Hot Stocks
Breaking Hot Stocks news story on NewStar Financial »

NewStar Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JRVR

James River Group

$41.95

-0.08 (-0.19%)

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Initiation
James River Group initiated  »

James River Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

MDB

MongoDB

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Syndicate
MongoDB IPO deal range increased to $20.00-$22.00 »

MongoDB 's 8M share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

NFLX

Netflix

$202.68

3.19 (1.60%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PSX

Phillips 66

$90.87

-3.56 (-3.77%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Phillips 66 analyst commentary  »

Phillips 66 price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

VZ

Verizon

$48.09

0.23 (0.48%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Periodicals
Verizon FiOS stops carrying Univision, WSJ reports »

Verizon FiOS has stopped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

VLO

Valero

$77.42

-0.66 (-0.85%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Recommendations
Valero analyst commentary  »

Valero price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SNDX

Syndax

$12.76

0.39 (3.15%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Syndicate
Syndax raises $25M in a registered direct offering »

Syndax announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Immune Design to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

ANDV

Andeavor

$103.82

-1.55 (-1.47%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Recommendations
Andeavor analyst commentary  »

Andeavor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$30.87

-1.05 (-3.29%)

07:23
10/17/17
10/17
07:23
10/17/17
07:23
Initiation
Tactile Systems initiated  »

Tactile Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

AGN

Allergan

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Recommendations
Allergan analyst commentary  »

Allergan court ruling on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

GRPN

Groupon

$4.70

0.07 (1.51%)

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Initiation
Groupon initiated  »

Groupon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 16

    Nov

FANG

Diamondback Energy

$102.60

1.23 (1.21%)

07:21
10/17/17
10/17
07:21
10/17/17
07:21
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

UNFI

United Natural Foods

$40.57

0.09 (0.22%)

, AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

07:21
10/17/17
10/17
07:21
10/17/17
07:21
Downgrade
United Natural Foods, Amazon.com rating change  »

United Natural Foods…

UNFI

United Natural Foods

$40.57

0.09 (0.22%)

AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

07:19
10/17/17
10/17
07:19
10/17/17
07:19
General news
Futures flat following yesterday's advance »

Stock futures are flat…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.